Gene therapy that induces the body to create microRNA-22, or miR-22, a naturally occurring molecule, successfully treated mice with hepatocellular carcinoma in a study at the UC Davis Comprehensive Cancer Center. The miR-22 treatment also reduced liver inflammation and produced better survival outcomes compared to the FDA-approved liver cancer treatment lenvatinib.
The University of Arkansas for Medical Sciences College of Medicine invested Mauricio S. Garcia in the Jerome S. Levy, MD, Chair in Gastroenterology and Hepatology during a May 1 ceremony.
